Abstract
Objective: The effect of levosimendan (LS) has been researched in a limited number of end-stage renal disease patients (ESRDPs). However, LS has not previously been studied in coronary artery bypass grafting (CABG) patiens with renal impairement. Our aim of this study was to investigate the effect of LS on postoperative hemodynamic effects in hemodialyses dependent patients undergoing CABG.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
